Business Wire

LILIUM-OTSUKA-CO.,-LTD.

2.10.2015 14:01:58 CEST | Business Wire | Pressemeddelelse

Del
Lilium Otsuka: Lilium® α-200, a Continuous Urine Volume Sensor, Will Be Launched in Japan

Lilium Otsuka Co., Ltd., a subsidiary of Otsuka Holdings Co., Ltd. will begin selling the Lilium® α-200, a continuous, non-invasive bladder urine volume sensor, on November 2, 2015.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20151002005301/en/

This product makes it possible to continuously monitor urination schedules in patients who have lost the urge to urinate. It is anticipated that this will alleviate the need for daily, lifestyle-restricting indwelling bladder (“Foley”) catheters and the anxiety of incontinence.

Problems with urination independence and control are known to determine the ability of patients to return home from the hospital, and impose a heavy burden on nursing and caregiving services. Lilium α-200 is expected to greatly contribute to the improvement of patient quality of life, and to reduce labor and improve the efficacy of those engaged in nursing and caregiving. Further, Lilium Otsuka expects to make a significant contribution to holistic treatments which impact the dignity of patients.

“For patients with loss of urge or urinary difficulty, the beauty of this product lies in its ability to accurately monitor the size of the bladder (a measure of volume of urine retained in the bladder) and the ability to schedule bathroom trips or self-catheterization.” said Dr. Osamu Yokoyama M.D., Ph.D., president of the Japanese Continence Society and professor on the Faculty of Medical Sciences, the University of Fukui, “As the Japanese Continence Society initiates a certified physician system next year to begin training doctors who can professionally manage continence care, this device is thought to provide a good method to support discharge of patients to their homes.”

About Lilium Otsuka

Lilium Otsuka is a subsidiary company of Otsuka Holdings Co., Ltd. (TOKYO:4578) established in Kanagawa, Japan. It is dedicated to standardizing the practice of measuring urinary volume as a “fifth vital sign” through developing innovative bladder health products.

About Lilium ® α-200

Lilium® α-200 is an innovative, hand-held urine volume sensor which works with two AA batteries. The device measures not only bladder urine residual but also provides alerts on appropriate timing for clean-intermittent catheterization through continuous urine volume measurement.

Contact:

Keiko Yoshimura
Lilium Otsuka Co., Ltd.
+81-42-704-3822
lilium_info@otsuka.jp
Website link: http://lilium200.jp/index-en.html

Link:

ClickThru

Information om Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Følg pressemeddelelser fra Business Wire

Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.

Flere pressemeddelelser fra Business Wire

Eighteen48 Partners Announces First Close of Eighteen48 Private Equity Fund I at €175 million14.5.2026 13:56:00 CEST | Press release

Eighteen48 Partners today announced the first close of Eighteen48 Private Equity Fund I (the “Fund”) at €175 million. The Fund, which is targeting €350 million, is focused on European middle-market buyout transactions sourced through Independent Sponsors. Since 2020 Eighteen48 Partners have deployed more than €200 million into this strategy, which aims to provide investors with diversified exposure to off-market sourced transactions. The first close was supported by significant re-up commitments from Eighteen48 clients as well as commitments from institutions, family offices and UHNWs, underscoring the strength of the firm’s platform, track record and experience as well as growing momentum in the Independent Sponsor space. Julien Sevaux, Founding Partner and CEO, commented: “We are increasingly excited by the opportunity in the growing independent sponsor segment of European private equity - a corner of the market we believe remains largely overlooked by investors yet offers compelling

Klarna Delivers Strong Start to 2026 With $1Bn Revenue and $68M Adj. Operating Profit14.5.2026 13:30:00 CEST | Press release

Klarna, the global digital bank and flexible payments provider, today reported first quarter 2026 results. GMV reached $33.7 billion (+33% YoY), revenue $1.0 billion (+44% YoY), transaction margin dollars $389 million (+44% YoY), and adjusted operating profit $68 million, up from $3 million a year ago. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260514241288/en/ "Klarna addresses the entire consumer wallet: Pay Now for everyday spending and saving, Pay Later our charge card equivalent at 0% interest for mid-size ticket spending, and POS installments (Fair Financing) for big-ticket purchases. In Q1 we executed well across all the business, driving every line of our P&L and compounding growth across our global network. Growing network. Same three products. Deeper consumer engagement.” Sebastian Siemiatkowski, CEO & Co-Founder, Klarna Q1 2026 Highlights GMV: $33.7 billion (+33% YoY); U.S. +39%, ex-U.S. +31% Revenue: $1.0 bil

SBC Medical Group Holdings Announces First Quarter 2026 Financial Results14.5.2026 12:30:00 CEST | Press release

SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Medical Services Organization providing management support across a wide range of healthcare fields, today announced its financial results for the three months ended March 31, 2026. First Quarter 2026 Highlights Total revenues were $43 million, representing a 9% year-over-year decrease. Net income attributable to SBC Medical Group Holdings Incorporated was $11 million, representing a 47% year-over-year decrease. Net income margin was 26% for the first quarter of 2026, representing a year-over-year decrease of 19 percentage points. Earnings per share, which is defined as net income attributable to the Company divided by the weighted average number of outstanding shares, was $0.11 for the three months ended March 31, 2026, representing a 48% year-over-year decrease. EBITDA1, which is calculated by adding depreciation and amortization expense to income from operations was $18 million, representing a

Compass Pathways to Participate in RBC Capital Markets Global Healthcare Conference on May 19-20, 202614.5.2026 12:30:00 CEST | Press release

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will attend the RBC Capital Markets Global Healthcare Conference on May 19-20, 2026 and will participate in a fireside chat on May 19 at 10:00am ET. A live audio webcast of this event will be accessible from the “Events” page of the Investors section of the Compass website. A replay of the webcast will be accessible for 30 days following each event. About Compass Pathways Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. We are motivated by the need to find better ways to help and empower people with serious mental health conditions who are not helped by existing treatments. We are pioneering a new paradigm for treating mental health conditions focused on rapid and durable responses through the development of

FPT Strengthens Bavarian Presence with New Munich Office, Accelerating AI Transformation14.5.2026 11:13:00 CEST | Press release

Global technology corporation FPT officially cut the ribbon on its latest office in Germany. This milestone reinforces the company's long-term commitment to delivering AI-driven services to its growing customer base across Germany and the wider European market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260514689341/en/ The inauguration ceremony was attended by H.E. Mr Nguyen Dac Thanh, Ambassador of Vietnam to Germany, alongside representatives from the local government, FPT executives, and key partners. Situated in one of Europe’s most dynamic technological and manufacturing hubs, the Munich office strengthens FPT’s delivery capabilities and enables faster, more scalable engagement across the region. The move underscores the company’s strategic focus on investing in key innovation hubs to meet rising demand for AI transformation and accelerate time-to-value for clients. "Our expanded presence in Munich allows us to sta

I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.

Besøg vores nyhedsrum
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye